New axon guidance antibody alert 🧪 ➕ Anti-#SEMA6A/7A ➕ Anti-#NRP1 IPI recombinant monoclonals are designed to be mouse- and human-reactive, non-cross-reactive with other protein family members and IPI-validated for flow cytometry and immunofluorescence. View the datasheets: buff.ly/G35AqDh

Less than one month left to register for IPI’s Automated Liquid Handling course 🔔 This course is designed by IPI’s automation team to provide students, researchers, and lab personnel at all levels with support and hands-on skills for developing large-scale assays. Grab your spot: buff.ly/pnh3UtQ

Meet #AlloyScholar Shelby Harris! Shelby, a @vanderbilt.edu PhD student, joined our 2026 Yeast Display course to learn #Abengineering methods to study G6P's role in #glucoseproduction. Thanks Alloy Therapeutics for supporting this year’s Scholars! Get IPI updates: buff.ly/a7XyBij

Just out @cellpress.bsky.social! Led by Deepash Kothiwal & co-authored by 20+ IPI lab members, the paper reports a novel framework to streamline antibody development, generate ML-compatible datasets and identify functional binders missed by experimental selection. Read the paper: buff.ly/Qq5OnMu

Looking for a dependable #isotypecontrol antibody? Our #MOPC-21 recombinant rabbit IgG is compatible with all IPI rabbit IgG antibodies and, as a consistent non-binder, supports accurate assessment of family-wide cross-reactivity. Order now: buff.ly/gU0M1ZE

#AlloyScholar Lorenzo Agostini (NIH) joined IPI’s #YeastDisplay course this month to learn cutting-edge antibody discovery and engineering techniques alongside fellow translational researchers. Thanks, Alloy Therapeutics, for the support! Get IPI education updates: buff.ly/a7XyBij

IPI platform director André Teixeira walked through the architecture of IPI’s platform, built to combine #yeastsurfacedisplay, #labautomation and #AI-guided clone triage toward faster #antibodydiscovery. Listen to the full talk @milaboratories.bsky.social ➡️

Scale-up and automate your workflows! Join us for a two-day interactive course, happening July 23-24. Register now: buff.ly/GWBG1yq

Deb Moshinsky, IPI characterization and validation director, will speak on a panel at Reproducibility in Science: Elevating Standards to Strengthen Research next week! Join her at Hood College on June 17! More info: bit.ly/4au4hVM

Last week’s course was a big success, thanks to our guest speakers! Dane Wittrup @mitkochinstitute.bsky.social, Surge Biswas at Nabla Bio & Justin Peruzzi @aiproteins.com shared insights on yeast display, AI Ab design & miniprotein discovery. Sign up for future course updates ➡️ buff.ly/tTcDWZk

We needed a reliable recombinant rabbit IgG #isotypecontrol—so we built one. Designed as a consistent non-binder, IPI-MOPC21 helps assess family-wide #crossreactivity with confidence. And it’s now available as part of our basic protein tool collections: buff.ly/gU0M1ZE

Researchers at IPI and Alloy Therapeutics are hoping AI advances will help make drug discovery less expensive, faster and better — especially when it comes to nanobody therapeutics. Read more: buff.ly/8ZBqnYs

It’s the last day of a great week training on #antibodydiscovery techniques, practicing cell sorts, and learning all about the utility of yeast display! Thanks to Sony Biotechnology the support & sharing #flowcytometry/#cellsorting insights! Get IPI ed pdates: buff.ly/ZKR3alr

Another day of #yeastdisplay! Today, students learned #antigenbiotinylation, #FACS, and #AIproteindesign. Thanks to today’s sponsor, Alloy Therapeutics, for sharing more on #antibodydiscovery via mammalian cell-based directed evolution! News on courses and events: buff.ly/ZKR3alr

Our #yeastdisplay course is off to a great start with an intro to the basics of #displaytechnology, #librarycreation & #cellsorting. Thank you to sponsor @twistbioscience.com & Steven Thomas for offering strategies to build effective/diverse libraries! Find out about future courses: buff.ly/ZKR3alr

New antibody alert 🧪 ➕ Anti-#SEMA3A/C/D/E/F ➕ Anti-#NRP2 ➕ Anti-#CNTN2 (TAG-1) IPI #recombinantmonoclonals are designed to be mouse/human reactive, do not cross-react w/other protein family members & are IPI-validated for #flowcytometry/ #immunofluorescence. View the datasheets: buff.ly/7SE9WnB

Still thinking about the conversations & energy from last week at the Forbes #America250 Expo! It was inspiring to connect with so many people, share more about IPI's role in #basicresearch & #drugdiscovery, and celebrate the many achievements of our founder @timothyspringer.bsky.social!

Join us in Boston this July for an intensive, hands-on training led by IPI’s automation team & sponsored by SPT Labtech. Register to learn the basics of #liquidhandling, #methoddevelopment and #automation for #antibodydiscovery ➡️ buff.ly/3f3vP8Y 📅 July 23–24, 2026 📍 Boston, MA 👥 Only 5 spots left

#VHHs (#nanobodies) are powerful—but their “camel-ness” makes #humanization and #optimization challenging. IPI and Alloy Therapeutics are tackling this with a fine-tuned #yeastdisplay platform that can bypass frustrating traps. Read more:

Spend two days with IPI automation experts this summer 🤝 Start automating workflows in your lab Sign up for our “Introduction to Automated Liquid Handling” course, happening right here in Boston July 23-24, 2026. Sign up now: buff.ly/viOaakH

It's been a busy week! Our team flooded #PEGSBoston with posters and a lab automation short course, presented at @canacn.bsky.social's Montréal meeting alongside @addgene.bsky.social & made a special appearance at #Forbes250 in SF! Great to connect with collaborators and share our science!

Scale-up and automate your workflows with IPI’s interactive course, July 23-24, featuring: Lectures + Q&As with IPI experts A tour of automated systems for protein science Robots + method development skills A lunch + learn from our sponsor, SPT Labtech Register now: buff.ly/MR3iVXI

Catch IPI team & our founder @timothyspringer.bsky.social at the @forbes.com America Innovates Expo this weekend! Swing by our booth to: 🤖 Watch robots in action 🧬 Check out our antibody cartoons 💬 Chat with scientists who love what they do Tickets are still up for grabs 👉

What’s a VHH? Think of it like a tiny Lego-like antibody with untapped therapeutic potential. Learn more about how IPI and Alloy Therapeutics are partnering to put them to use: buff.ly/pfaRBaa

Need help automating workflows in your lab? IPI’s automation team is running a hands-on course July 23-24 on the core principles w/ a tour of #labautomation systems for #proteinscience workflows & roundtable discussions on automating from scratch. Learn more and register: buff.ly/ZclonG9

Find IPI at #PEGSBoston next week! We’re running a short course on automated liquid handling, are giving talks on quantitative characterization and codon optimization, and have posters on discovery campaigns & methods. Find all the details!

Alloy Therapeutics and IPI are putting our heads together to power next-generation antibody discovery. Thanks for sharing the details, André Teixeira and Nikolai Suslov! Read more: buff.ly/zllPJqr

Join us in person this July to learn the principles of #automatedliquidhandling, gain hands-on liquid handler #robot experience, develop methods with #Python, and get expert advice on how to build and optimize automation for #laboratorypipelines. Register now, spots are limited ➡️ buff.ly/qo7fcD2

IPI is heading to SF for the @forbes.com America Innovates Expo in celebration of our founder @timothyspringer.bsky.social (@springerlab.bsky.social), named one of Forbes’ 250 Great American Innovators. Stop by our booth May 16–18 at the Gateway Pavilion. Free tickets: buff.ly/2WTLN2y

IPI is excited to partner with Alloy Therapeutics to advance next-gen antibody discovery! Our team created two synthetic humanized VHH libraries designed for stability, developability, and versatility—helping accelerate therapeutic timelines. 🔗Learn more: buff.ly/W34tUx8

Looking for integrin antibodies? With the recent addition of Anti-Integrin beta 1 [IPI-TS2/16] and Anti-Integrin beta 2 [IPI-TS1/18], our Integrin Antibody Collection now comprises nearly 30 antibodies! View the collection: buff.ly/a52As0G

Organisms have distinct preferences in the #codons used to translate DNA into #aminoacids. Biologists typically match a model’s bias to keep its #translational machinery working smoothly. But new research from IPI suggests things may be a little more complicated—or more simple ➡️ buff.ly/QqIb53c

Build in-demand #labautomation skills with IPI. Join our 2-day, hands-on course this July in Boston—now open to the broader scientific community. Learn from IPI experts designing real-world systems for #antibodyproduction and #antibodydiscovery. 8 spots available. Register now: buff.ly/SXchNgO

IPI is building new antibodies to label #glialcellstates at the #protein level. Our Friday workshop brought researchers together to discuss: How can protein markers assist in glia state identifications? Which #antibodies would be most impactful for the community? Which targets are most critical?

We had a great two days with Just A Start Biotechnology Careers Program alumni! Thanks to all who joined us for a hands-on course on lab automation, liquid handling and assay design basics 🥼 🧪

Congratulations to our 2026 Alloy Scholars, Shelby Harris & Lorenzo Agostini! Sponsored by our partner, Alloy Therapeutics, these exceptional scientists will have the opportunity to gain hands-on training in our June Yeast Display course & bring this knowledge back to their labs.

IPI is excited to announce that we’ve opened our course in laboratory automation to the scientific community! Register to learn the basics of liquid handling, method development and automation for antibody discovery ➡️ buff.ly/vs162WJ 📅 July 23–24, 2026 📍 Boston, MA 👥 Only 8 spots available

More than 50 researchers joined us yesterday for our #adhesionGPCR targets workshop! Thanks to all who participated to help us prioritize targets & design purpose-built #Abs. Interested in joining future workshops on #glialcellphenotyping & #synapticcleftsignaling? Get updates ➡️ buff.ly/9uAso7K

New integrin antibodies targeting integrin beta 1 and beta 2 just joined the IPI collections 🧪 These recombinant monoclonals recognize human targets, do not cross-react with other protein family members and are recommended for flow cytometry. Order now: buff.ly/VpcxzlC

We’re excited to welcome alumni from Just A Start’s Biotechnology Careers Program to a 2-day automation course next week, made possible through support from the Mass Life Sciences Center Pathmaker program! More soon 🔬 Sign up for updates on future courses ⬇️

Stanford researcher Stephen Quake imagines IPI as a modern-day Library of Alexandria, preserving and activating protein knowledge to influence how a whole new generation of therapies will be made. That’s why he’s joined forces as part of our Board of Directors. Learn more: buff.ly/PmIpnht

#Robo3 antibodies are crucial for detecting the Roundabout Guidance Receptor 3 protein & studying neuraldevelopment & #axonnavigation—but reliable #antibodies are in short supply. IPI just released two anti-ROBO3s that might help. Dive into the data on our product pages ➡️ buff.ly/kk4fLJJ

In a recent study, the IPI team tested 5 codon optimization schemes (including #NativeCodons) in the construction/expression of 18 neurologically relevant human & murine #glycoproteins. See which yielded the most proteins ➡️ buff.ly/TaFaWkY

There’s a lot of hype around #AI & #proteindesign, but there are some important considerations—including how these molecules perform in laboratory conditions, says IPI's platform director André Teixeira. Read more from Teixeira in this Science Arena article ➡️

This former HHMI investigator and CZI leader was determined to keep exploring life’s smallest pieces in pursuit of large-scale scientific impact. So he’s returned to his Stanford lab and joined an effort to advance protein science. Read his story: buff.ly/ciTChrs

New #Robo #Slit antibodies just joined the IPI collections 🧪 Recommended for flow, ICC and IHC, these chimeric #recombinantproteins are specific to human and mouse targets and do not cross-react with other family members. #axonguidance #neuronalmigration buff.ly/mtViWPa

📣LAST CHANCE! Applications for our 2026 yeast display course are due TODAY 📣 Come learn the basics of #yeastdisplaylibrary prep, MACS & FACS sorts, and #AI-enabled discovery in just 5 days — directly from yeast display leaders and working scientists. Apply now! buff.ly/4Y5YvwK

Don't have a favorite part of #antibodydiscovery? Maybe you'll find it in our 5 day #yeastdisplay course this summer! Apply now — applications close March 30th ⏲️ buff.ly/oBlGknl

New antibody release! We've expanded our catalog of synaptic cleft antibodies with @ipiproteins.bsky.social's new antibodies targeting neurexins and neuroligins. Find these and more in our IPI Collection page:

Exciting update: Alloy Therapeutics will be funding two scholarships to attend IPI's 5 day course on yeast display technology for antibody discovery! The course is open to postdocs, students, faculty & industry scientists. Scholarships will go to top candidates who apply by 3/30 ⏰ buff.ly/av8zOGo